Literature DB >> 14634746

[Merkel cell carcinoma. Clinical and histological differential diagnosis, diagnostic approach and therapy].

B Khan Durani1, W Hartschuh.   

Abstract

Merkel cell carcinomas are rare tumors of the skin with an aggressive behavior and frequent regional and distant metastases. Typically, the primary is a fast-growing, painless, reddish nodule with an iceberg-like effect, broadening in the depth. On the trunk and the buttocks, deep clinically rather inconspicuous nodules can occur. The clinical differential diagnosis of the Merkel cell carcinoma includes skin metastases, malignant lymphomas, malignant adnexal tumors and cysts when the tumor is located deep in the soft tissue (e.g. on the buttocks). Histological and immunohistochemical analysis is necessary for the diagnosis. The demonstration of cytokeratin 20 in the typical globular distribution pattern is of main importance in the diagnosis of Merkel cell carcinoma. Because they are very rare, Merkel cell carcinomas are infrequently diagnosed clinically, in spite of the rather characteristic picture. Diagnostic excision with a safety margin of 3 cm is recommended followed by an adjuvant radiotherapy. The radiation field should include the area of the draining vessels and the first regional lymph nodes. There are some reports concerning the advantage of sentinel lymph node biopsy. In distant metastases, the therapy is multimodal and palliative including surgery, radiation and chemotherapy. Because of the high incidence of regional and distant metastases, regular follow-up is important.

Entities:  

Mesh:

Year:  2003        PMID: 14634746     DOI: 10.1007/s00105-003-0633-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  26 in total

1.  Positron emission tomographic imaging of Merkel cell carcinoma.

Authors:  Ba D Nguyen
Journal:  Clin Nucl Med       Date:  2002-12       Impact factor: 7.794

2.  Somatostatin analogue scintigraphy in Merkel cell tumours.

Authors:  B K Durani; A Klein; M Henze; U Haberkorn; W Hartschuh
Journal:  Br J Dermatol       Date:  2003-06       Impact factor: 9.302

3.  Merkel cell carcinoma: the role of radiation therapy in general management.

Authors:  M Bischof; M van Kampen; P Huber; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1999-12       Impact factor: 3.621

4.  Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites.

Authors:  J K Chan; S Suster; B M Wenig; W Y Tsang; J B Chan; A L Lau
Journal:  Am J Surg Pathol       Date:  1997-02       Impact factor: 6.394

5.  Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation.

Authors:  E J Lunder; R S Stern
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

6.  Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung.

Authors:  A J Hanly; G W Elgart; M Jorda; J Smith; M Nadji
Journal:  J Cutan Pathol       Date:  2000-03       Impact factor: 1.587

7.  Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas.

Authors:  W Cheuk; M Y Kwan; S Suster; J K Chan
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

8.  Merkel cell carcinoma. Prognosis and management.

Authors:  A Yiengpruksawan; D G Coit; H T Thaler; C Urmacher; W K Knapper
Journal:  Arch Surg       Date:  1991-12

9.  Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck.

Authors:  H Goepfert; D Remmler; E Silva; B Wheeler
Journal:  Arch Otolaryngol       Date:  1984-11

10.  Trabecular carcinoma of the skin: an ultrastructural study.

Authors:  C K Tang; C Toker
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.